Related references
Note: Only part of the references are listed.Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease
C. Pipili et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Potential Benefit of Telbivudine on Renal Function Does Not Outweigh Its High Rate of Antiviral Drug Resistance and Other Adverse Effects
Suna Yapali et al.
GASTROENTEROLOGY (2014)
Telbivudine Improves Renal Function in Patients With Chronic Hepatitis B
Edward J. Gane et al.
GASTROENTEROLOGY (2014)
Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B
Mio Tanaka et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment
James Fung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure
Sophie Jose et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection
David M. Gracey et al.
ANTIVIRAL THERAPY (2013)
Association Between Tenofovir Exposure and Reduced Kidney Function in a Cohort of HIV-Positive Patients: Results From 10 Years of Follow-up
Claudie Laprise et al.
CLINICAL INFECTIOUS DISEASES (2013)
TENOFOVIR DF (TDF) IS SAFE AND WELL TOLERATED IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH PRE-EXISTING MILD RENAL IMPAIRMENT
S. Fung et al.
JOURNAL OF HEPATOLOGY (2013)
Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate
P. Pradat et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Update on tenofovir toxicity in the kidney
Andrew M. Hall
PEDIATRIC NEPHROLOGY (2013)
Association of tenofovir exposure with kidney disease risk in HIV infection
Rebecca Scherzer et al.
AIDS (2012)
Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B
N. Gara et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B
Robert G. Gish et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients
Yu Jin Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: A European multicenter study
Si-Nafa Si-Ahmed et al.
ANTIVIRAL RESEARCH (2011)
Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B
Stefan Mauss et al.
JOURNAL OF HEPATOLOGY (2011)
Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus
A. Tamori et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Renal Dysfunction in Chronic Hepatitis B Patients Treated with Adefovir Dipivoxil
Nghi B. Ha et al.
HEPATOLOGY (2009)
Share Paper
